Delirium in a Male Patient Following Recovery from Mild COVID-19 Infection
Yasir I. Alsenaidi, Khalid F. Alsadhan, Mohammed W. Alwhibi, Hessah I. Almezail, Abdullah A. Alrasheed
Journal of Pharmaceutical Research International · pp. 169–173 · Published 29 Sep 2021
10.9734/jpri/2021/v33i45A32730Abstract
COVID-19 has had a worldwide impact that is unprecedented and catastrophic. Infection with COVID-19 can cause various neuropsychiatric complications, including delirium, which is commonly reported with the acute phase of illness with COVID-19 infection. However, delirium after complete recovery from mild COVID-19 infection has never been reported. Here we present the first case for a 58-year-old male diagnosed with a positive COVID-19 infection with a PCR test after a 1-day history of headaches and loss of taste and smell. By 10 days after the positive PCR test, the patient recovered completely without any recurrence of symptoms. However, the patient was observed to be unaware of their surroundings and displayed changes in their behaviour 11 days after recovery from mild COVID-19 infection. Physical examinations were abnormal, while the lab tests and the brain images showed normal results. The patient started to improve on the second day of admission without presenting any decline in health. Delirium that develops after recovering from COVID-19 infection should be investigated thoroughly to determine the reason; if no clear cause can be identified, the delirium may be secondary to COVID-19 infection.
Cited by 0
No indexed citations yet.
Related research
- Covid-2019:“A Microbiological Monster” — shares topic coverage
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Early Treatment with Hydroxychloroquine Improves Clinical Outcomes and Reduces Hospital Admissions in COVID-19 Associated Pneumonia — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.